Irreversible laryngeal palsy: An induced complication of carboplatin 450mg/m2 and paclitaxel 250mg/m2 - Case report

Introduction: Unilateral vocal cord paralysis is common than bilateral palsy and is mostly idiopathic in origin. Other causes may include malignancy, secondary to neck or recurrent laryngeal nerve trauma, intubation or secondary to surgery however, taxanes induces paresis which can lead to paralysis...

Full description

Bibliographic Details
Main Authors: Rawish Kumar, Sanjay K. Munjal, Naresh K. Panda
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Otolaryngology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468548817301868
_version_ 1828821897931915264
author Rawish Kumar
Sanjay K. Munjal
Naresh K. Panda
author_facet Rawish Kumar
Sanjay K. Munjal
Naresh K. Panda
author_sort Rawish Kumar
collection DOAJ
description Introduction: Unilateral vocal cord paralysis is common than bilateral palsy and is mostly idiopathic in origin. Other causes may include malignancy, secondary to neck or recurrent laryngeal nerve trauma, intubation or secondary to surgery however, taxanes induces paresis which can lead to paralysis following paresis of larynx. Case summary: A female patient presented with cancer of cervix (Endometrium) and developed vocal cord paralysis after completion of five cycles of treatment with injections paclitaxel 250mg/m2 and carboplatin 450mg/m2. Patient's stroboscopic examination, electromyography (EMG) confined that one vocal cord lateralized in paramedian position. Voice analysis revealed low pitch and loudness and with breathy quality. Discussion: The vocal cord paralysis was believed to have occurred due to neurotoxic effect of carboplatin and paclitaxel, as an added complication of these drugs. Carboplatin and paclitaxel above than cumulative dose can induce bilateral or unilateral vocal cord paresis or sometimes paralysis also. The concurrent amount of dose used of carboplatin and paclitaxel might have contributed to this illness in patient.
first_indexed 2024-12-12T13:03:28Z
format Article
id doaj.art-db522fa351274d8f87c1f41a65ff1ddf
institution Directory Open Access Journal
issn 2468-5488
language English
last_indexed 2024-12-12T13:03:28Z
publishDate 2018-03-01
publisher Elsevier
record_format Article
series Otolaryngology Case Reports
spelling doaj.art-db522fa351274d8f87c1f41a65ff1ddf2022-12-22T00:23:43ZengElsevierOtolaryngology Case Reports2468-54882018-03-016C383910.1016/j.xocr.2018.01.004Irreversible laryngeal palsy: An induced complication of carboplatin 450mg/m2 and paclitaxel 250mg/m2 - Case reportRawish KumarSanjay K. MunjalNaresh K. PandaIntroduction: Unilateral vocal cord paralysis is common than bilateral palsy and is mostly idiopathic in origin. Other causes may include malignancy, secondary to neck or recurrent laryngeal nerve trauma, intubation or secondary to surgery however, taxanes induces paresis which can lead to paralysis following paresis of larynx. Case summary: A female patient presented with cancer of cervix (Endometrium) and developed vocal cord paralysis after completion of five cycles of treatment with injections paclitaxel 250mg/m2 and carboplatin 450mg/m2. Patient's stroboscopic examination, electromyography (EMG) confined that one vocal cord lateralized in paramedian position. Voice analysis revealed low pitch and loudness and with breathy quality. Discussion: The vocal cord paralysis was believed to have occurred due to neurotoxic effect of carboplatin and paclitaxel, as an added complication of these drugs. Carboplatin and paclitaxel above than cumulative dose can induce bilateral or unilateral vocal cord paresis or sometimes paralysis also. The concurrent amount of dose used of carboplatin and paclitaxel might have contributed to this illness in patient.http://www.sciencedirect.com/science/article/pii/S2468548817301868CarboplatinPaclitaxelLaryngeal palsyVoiceNeurotoxic
spellingShingle Rawish Kumar
Sanjay K. Munjal
Naresh K. Panda
Irreversible laryngeal palsy: An induced complication of carboplatin 450mg/m2 and paclitaxel 250mg/m2 - Case report
Otolaryngology Case Reports
Carboplatin
Paclitaxel
Laryngeal palsy
Voice
Neurotoxic
title Irreversible laryngeal palsy: An induced complication of carboplatin 450mg/m2 and paclitaxel 250mg/m2 - Case report
title_full Irreversible laryngeal palsy: An induced complication of carboplatin 450mg/m2 and paclitaxel 250mg/m2 - Case report
title_fullStr Irreversible laryngeal palsy: An induced complication of carboplatin 450mg/m2 and paclitaxel 250mg/m2 - Case report
title_full_unstemmed Irreversible laryngeal palsy: An induced complication of carboplatin 450mg/m2 and paclitaxel 250mg/m2 - Case report
title_short Irreversible laryngeal palsy: An induced complication of carboplatin 450mg/m2 and paclitaxel 250mg/m2 - Case report
title_sort irreversible laryngeal palsy an induced complication of carboplatin 450mg m2 and paclitaxel 250mg m2 case report
topic Carboplatin
Paclitaxel
Laryngeal palsy
Voice
Neurotoxic
url http://www.sciencedirect.com/science/article/pii/S2468548817301868
work_keys_str_mv AT rawishkumar irreversiblelaryngealpalsyaninducedcomplicationofcarboplatin450mgm2andpaclitaxel250mgm2casereport
AT sanjaykmunjal irreversiblelaryngealpalsyaninducedcomplicationofcarboplatin450mgm2andpaclitaxel250mgm2casereport
AT nareshkpanda irreversiblelaryngealpalsyaninducedcomplicationofcarboplatin450mgm2andpaclitaxel250mgm2casereport